Genome-wide gene expression profiling of human narcolepsy

Gene Expression

Volumn 15, Issue 4, 2012, Pages 171-181

  Bernardini, Camilla ^a   Lattanzi, Wanda ^a   Bosco, Paolo ^b   Franceschini, Christian ^c   Plazzi, Giuseppe ^c   Michetti, Fabrizio ^a   Ferri, Raffaele ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cataplexy; Gene expression; Microarray; Narcolepsy

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 2',5' OLIGOADENYLATE SYNTHETASE; AMYLOID PRECURSOR PROTEIN; BINDING PROTEIN; CYCLOOXYGENASE 1; HERMES ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; OREXIN 2 RECEPTOR; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PROSTAGLANDIN SYNTHASE; PROTEIN BPTF; PROTEIN COX5B; PROTEIN COX6A1; PROTEIN FAM128B; PROTEIN ISG15; PROTEIN KINASE WNK1; PROTEIN LARP4B; PROTEIN PAFAH1B1; PROTEIN PALM2; PROTEIN ROD1; PROTEIN TTC3; PROTEIN UBL5; PROTEIN ZNF652; RIBONUCLEOPROTEIN; TENASCIN; TETRATRICOPEPTIDE REPEAT PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; ARTICLE; BRAIN DEVELOPMENT; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; MALE; NARCOLEPSY; NUCLEOTIDE SEQUENCE; RNA ISOLATION;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ITALY; MALE; MIDDLE AGED; NARCOLEPSY; NERVE GROWTH FACTORS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPPING; RNA;

EID: 84863103836     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/105221612X13372578119652     Document Type: Article

References (55)

1. Albertson, D. N.; Pruetz, B.; Schmidt, C. J.; Kuhn, D. M.; Kapatos, G.; Bannon, M. J. Gene expression profile of the nucleus accumbens of human cocaine abusers: Evidence for dysregulation of myelin. J. Neurochem. 88:1211-1219; 2004.
2. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed: Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
3. Ashburner, M.; Ball, C. A.; Blake, J. A.; et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25:25-29; 2000.
4. Bernardini, C.; Lattanzi, W.; Businaro, R.; et al. Transcritpional effects of S100B on neuroblastoma cells: Perturbation of cholesterol homeostasis and interference on the cell cycle. Gene Expr. 14:345-359; 2010.
5. Berto, G.; Camera, P.; Fusco, C.; et al. The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and citron kinase. J. Cell Sci. 120:1859-1867; 2007.
6. Bi, W.; Sapir, T.; Shchelochkov, O. A.; et al. Increased LIS1 expression affects human and mouse brain development. Nat. Genet. 41:168-77; 2009.
7. Bolstad, B. M.; Irizarry, R. A.; Astrand, M.; Speed, T. P. A comparison of normalization methods for high density oligonucleotidearray data based on variance and bias. Bioinformatics 19:185-193; 2003.
8. Borovecki, F.; Lovrecic, L.; Zhou, J.; et al. Genome- wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. USA 102:11023-11028, 2005.
9. Brazma, A.; Hingamp, P.; Quackenbush, J.; et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29:365-371; 2001.
10. Cave, H. Narcolepsy. Arch. Neurol. Psychiatr. 13:50-101; 1931.
11. Caylak, E. The genetics of sleep disorders in humans: Narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am. J. Med. Genet. A 149A: 2612-2626; 2009.
12. Colas, D.; Valletta, J. S.; Takimoto-Kimura, R.; Nishino, S.; Fujiki, N.; Mobley, W. C.; Mignot, E. Sleep and EEG features in genetic models of Down syndrome. Neurobiol. Dis. 30:1-7; 2008.
13. Daniels, L. Narcolepsy. Medicine 13:1-122; 1934.
14. Dauvilliers, Y.; Arnulf, I.; Mignot, E. Narcolepsy with cataplexy. Lancet 369:499-511; 2007.
15. Faissner, A.; Clement, A.; Lochter, A.; Streit, A.; Mandl, C.; Schachner, M. Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J. Cell Biol. 126:783-799; 1994.
16. Fukamauchi, F.; Aihara, O.; Kusakabe, M. Internalization and down-regulation of muscarinic acetylcholine receptors in cerebellar granule cells of tenascin-gene deficient mice. Neurochem. Int. 36:153-158; 2000.
17. Ge, K.; Guermah, M.; Yuan, C. X.; Ito, M.; Wallberg, A. E.; Spiegelman, B. M.; Roeder, R. G. Transcription coactivator TRAP220 is required for PPAR gamma 2- stimulated adipogenesis. Nature 417:563-567; 2002.
18. Helenius, K.; Yang, Y.; Alasaari, J.; Mäkelä, T. P. Mat1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipocyte differentiation. Mol. Cell. Biol. 29:315-323; 2009.
19. Honda, M.; Eriksson, K. S.; Zhang, S.; Tanaka, S.; Lin, L.; Salehi, A.; Hesla, P. E.; Maehlen, J.; Gaus, S. E.; Yanagisawa, M.; Sakurai, T.; Taheri, S.; Tsuchiya, K.; Honda, Y.; Mignot, E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One 4(1):e4254; 2009.
20. Honda, Y.; Doi, Y.; Ninomiya, R.; Ninomiya, C. Increased frequency of noninsulin-dependent diabetes mellitus among narcoleptic patients. Sleep. 9:254-259; 1986.
21. Irizarry, R. A.; Hobbs, B.; Collin, F.; Beazer-Barclay, Y. D.; Antonellis, J.; Scherf, U.; Speed, T. P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264; 2003.
22. Kawashima, M.; Tamiya, G.; Oka, A.; et al. Genomewide association analysis of human narcolepsy and a new resistance gene. Am. J. Hum. Genet. 79:252-263; 2006.
23. Lattanzi, W.; Bernardini, C.; Gangitano, C.; Michetti, F. Hypoxia-like transcriptional activation in TMT- induced degeneration: Microarray expression analysis on PC12 cells. J. Neurochem. 100:1688-1702; 2007.
24. Lattanzi, W.; Parrilla, C.; Fetoni, A.; et al. Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther. 15:1330-1343; 2008.
25. Lin, L.; Faraco, J.; Li, R.; Kadotani, H.; Rogers, W.; Lin, X.; Qiu, X.; de Jong, P. J.; Nishino, S.; Mignot, E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365-376; 1999.
26. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408; 2001.
27. Lopes, C.; Rachidi, M.; Gassanova, S.; Sinet, P. M.; Delabar, J. M. Developmentally regulated expression of mtprd, the murine ortholog of tprd, a gene from the Down syndrome chromosomal region 1. Mech. Dev. 84:189-193; 1999.
28. Maes, O. C.; Xu, S.; Yu, B.; Chertkow, H. M.; Wang, E.; Schipper, H. M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 28:1795-1809; 2007.
29. Martínez-Rodríguez, J. E.; Sabater, L.; Graus, F.; Iranzo, A.; Santamaria, J. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy. Sleep. 30(1):27-28; 2007.
30. Matsuki, K.; Grumet, F. C.; Lin, X.; Guilleminault, C.; Dement, W. C.; Mignot, E. HLADQB1-0602, rather than HLA DRw15(DR2), is the disease susceptibility gene in Black narcoleptics. Lancet 339:1052; 1992.
31. Mignot, E.; Tafti, M.; Dement, W. C.; Grumet, F. C. Narcolepsy and immunity. Adv. Neuroimmunol. 5:23-37; 1995.
32. Miyagawa, T.; Kawashima, M.; Nishida, N.; et al. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat. Genet. 40:1324-1328; 2008.
33. Niikura, T.; Hashimoto, Y.; Okamoto, T.; Abe, Y.; Yasukawa, T.; Kawasumi, M.; Hiraki, T.; Kita, Y.; Terashita, K.; Kouyama, K.; Nishimoto, I. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J. Neurosci. 21(6):1902-1910; 2001.
34. Nishimura, Y.; Martin, C. L.; Vazquez-Lopez, A.; et al. Genome-wide expression profiling of lymphoblast- oid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16: 1682-1698; 2007.
35. Nishino, S.; Ripley, B.; Overeem, S.; Lammers, G. J.; Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 355:39-40; 2000.
36. Nishio, T.; Kawaguchi, S.; Iseda, T.; Kawasaki, T.; Hase, T. Secretion of tenascin-C by cultured astrocytes: Regulation of cell proliferation and process elongation. Brain Res. 990:129-140; 2003.
37. Ongwijitwat, S.; Wong-Riley, M. T. Functional analysis of the rat cytochrome c oxidase subunit 6A1 promoter in primary neurons. Gene. 337:163-71; 2004.
38. Pan, D.; Fujimoto, M.; Lopes, A.; Wang, Y. X. Twist- 1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1alpha in brown fat metabolism. Cell 137: 73-86; 2009.
39. Peyron, C.; Faraco, J.; Rogers, W.; et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6:991-997; 2000.
40. Poli, F.; Plazzi, G.; Di Dalmazi, G.; et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 32:1491-1497; 2009.
41. Rachidi, M.; Lopes, C.; Gassanova, S.; et al. Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development. Mech. Dev. 93:189-193; 2000.
42. Saris, C. G.; Horvath, S.; van Vught, P. W.; et al. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genomics 10:405; 2009.
43. Schnepp, A.; Komp Lindgren, P.; Hülsmann, H.; Kröger, S.; Paulsson, M.; Hartmann, U. Mouse testican-2. Expression, glycosylation, and effects on neurite outgrowth. J. Biol. Chem. 280:11274-11280; 2005.
44. Schuld, A.; Hebebrand, J.; Geller, F.; Pollmächer, T. Increased body-mass index in patients with narcolepsy. Lancet 355:1274-1275; 2000.
45. Shekarabi, M.; Girard, N.; Rivière, J. B.; et al. Mutations in the nervous system - specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J. Clin. Invest. 118(7):2496-2505; 2008.
46. Suidan, G. L.; Dickerson, J. W.; Chen, Y.; et al. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J. Immunol. 184:1031-1040; 2010.
47. Tafti, M.; Nishino, S.; Aldrich, M. S.; Liao, W.; Dement, W. C.; Mignot, E. Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model. J. Neurosci. 16:4588-4595; 1996.
48. Tanaka, S.; Honda, Y.; Honda, M. Identification of differentially expressed genes in blood cells of narcolepsy patients. Sleep 30:974-979; 2007.
49. Tang, Y.; Lu, A.; Aronow, B. J.; Sharp, F. R. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease. Ann. Neurol. 50:699-707; 2001.
50. Thannickal, T. C.; Moore, R. Y.; Nienhuis, R.; et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474; 2000.
51. van den Berg, S. W.; Dollé, M. E.; Imholz, S.; van der A, D. L.; van't Slot, R.; Wijmenga, C.; Verschuren, W. M.; Strien, C.; Siezen, C. L.; Hoebee, B.; Feskens, E. J.; Boer, J. M. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: A population-based cohort study. Int. J. Obes. (Lond.) 33:1143-1152; 2009.
52. Vereecke, L.; Beyaert, R.; van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30:383-391; 2009.
53. Willie, J. T.; Chemelli, R. M.; Sinton, C. M.; Yanagisawa, M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24:429-458; 2001.
54. Wu, Z.; Irizarry, R. A. A statistical framework for the analysis of microarray probelevel data. Johns Hopkins University, Department of Biostatistics Working Papers, Working Paper 73, 2005. Retrieved from http: //www.bepress.com/jhubiostat/paper73
55. Zhang, Z.; Xu, X.; Zhang, Y.; Zhou, J.; Yu, Z.; He, C. LINGO-1 interacts with WNK1 to regulate nogo- induced inhibition of neurite extension. J. Biol. Chem. 284:15717-15728; 2009.